Novo Nordisk A/S vs Quanta Services Inc — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Quanta Services Inc trades at $639.3 (market cap $94.92B). The key difference: Novo Nordisk A/S is far larger — about 2.3× Quanta Services Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | PWR | |
|---|---|---|
Market Cap | $220.53B | $94.92B |
Sector | Health | Industrials |
52-Week High | $71.70 | $785.24 |
52-Week Low | $35.29 | $372.50 |
Enterprise Value | $239.49B | $100.88B |
Dividend Yield | 3.63% | 0.07% |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →